Increased Weight Gain and Insulin Resistance in HF-Fed PLTP Deficient Mice Is Related to Altered Inflammatory Response and Plasma Transport of Gut-Derived LPS

Archive ouverte

Lebrun, Lorène J | Pallot, Gaëtan | Nguyen, Maxime | Tavernier, Annabelle | Dusuel, Aloïs | Pilot, Thomas | Deckert, Valérie | Dugail, Isabelle | Le Guern, Naïg | Pais de Barros, Jean-Paul | Benkhaled, Anissa | Choubley, Hélène | Lagrost, Laurent, L. | Masson, David | Gautier, Thomas | Grober, Jacques

Edité par CCSD ; MDPI -

International audience. Bacterial lipopolysaccharides (LPS, endotoxins) are found in high amounts in the gut lumen. LPS can cross the gut barrier and pass into the blood (endotoxemia), leading to low-grade inflammation, a common scheme in metabolic diseases. Phospholipid transfer protein (PLTP) can transfer circulating LPS to plasma lipoproteins, thereby promoting its detoxification. However, the impact of PLTP on the metabolic fate and biological effects of gut-derived LPS is unknown. This study aimed to investigate the influence of PLTP on low-grade inflammation, obesity and insulin resistance in relationship with LPS intestinal translocation and metabolic endotoxemia. Wild-type (WT) mice were compared with Pltp-deficient mice (Pltp-KO) after a 4-month high-fat (HF) diet or oral administration of labeled LPS. On a HF diet, Pltp-KO mice showed increased weight gain, adiposity, insulin resistance, lipid abnormalities and inflammation, together with a higher exposure to endotoxemia compared to WT mice. After oral administration of LPS, PLTP deficiency led to increased intestinal translocation and decreased association of LPS to lipoproteins, together with an altered catabolism of triglyceride-rich lipoproteins (TRL). Our results show that PLTP, by modulating the intestinal translocation of LPS and plasma processing of TRL-bound LPS, has a major impact on low-grade inflammation and the onset of diet-induced metabolic disorders.

Suggestions

Du même auteur

Lipopolysaccharides and glucagon-like peptide 1 : from molecular mechanisms to pathophysiology. Lipopolysaccharides et glucagon-like peptide 1 : des mécanismes moléculaires à la physiopathologie

Archive ouverte | Lebrun, Lorène J | CCSD

Obesity and type 2 diabetes are metabolic diseases which have reached epidemic proportions worldwide. These metabolic disorders are related to a low grade inflammation whose molecular origin is still unknown. Previous studies have...

Could glucagon-like peptide-1 be a potential biomarker of early-stage intestinal ischemia?

Archive ouverte | Lebrun, Lorène J | CCSD

International audience. Intestinal ischemia, also called mesenteric ischemia, is a severe gastrointestinal and vascular medical emergency caused by a sudden decrease of blood flow through the mesenteric vessels. It ...

Phospholipid transfer protein (PLTP) and metabolic diseases

Archive ouverte | Grober, Jacques | CCSD

International audience. No abstract

Chargement des enrichissements...